BridgeMD
New treatment option for Institutionalization
Official title Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations
ClinicalTrials.gov ID: NCT07494110
What this study is testing
- What it's testing
- Aurora is an interdisciplinary project evaluating a chatbot-mediated supportive care intervention designed to promote emotional expression, autobiographical meaning-making, identity processes, and emotional well-being through guided narrative reconstruction. The Aurora system provides a structured, person-centered storytelling process supported by generative AI and human facilitation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Arm 1: Healthy Adults (Single-Session Intervention)
- Age 18 years or older at screening.
- Sufficient ability to read and understand Spanish to follow study instructions and complete questionnaires.
- Ability to engage in a brief guided interaction and complete self-report measures.
- Able and willing to provide written informed consent.
You likely can't join if
- Arm 1: Healthy Adults
- Current acute medical or psychiatric condition that would compromise safe participation or data validity.
- Moderate or high acute suicide or self-harm risk at screening.
- Significant cognitive, communication, or comprehension impairment that would interfere with participation.
- Explicit refusal to participate.
- \---
See the full eligibility criteria
- Arm 1: Healthy Adults (Single-Session Intervention)
- Age 18 years or older at screening.
- Sufficient ability to read and understand Spanish to follow study instructions and complete questionnaires.
- Ability to engage in a brief guided interaction and complete self-report measures.
- Able and willing to provide written informed consent.
- \---
- Arm 2: Adults with DSM-5 Diagnosed Mental Disorder in Residential Care (4-hour Intervention)
- Age 18 years or older at screening.
- Currently residing in a participating long-term mental health residential care facility and expected to remain there for the duration of the intervention and post-assessment period.
- Documented diagnosis of a mental disorder according to DSM-5 criteria, confirmed by the treating clinician.
- Minimal clinical stability at baseline, defined as all of the following:
- Clinically stable in the judgment of the treating clinician.
- No requirement for acute psychiatric hospitalization or crisis intervention in the previous 4 weeks.
- Clinical Global Impression - Improvement (CGI-I) score between 3 and 5 inclusive during the 4 weeks prior to enrollment, indicating relative clinical stability.
- Sufficient ability to understand spoken and written Spanish to participate in study procedures.
- Ability to engage in guided interaction and provide feedback.
- Able and willing to provide informed consent; when applicable, provision of legal guardian consent plus participant assent.
- Willingness to participate in all study procedures.
- \---
- Arm 3: Healthy Older Adults (≥65 Years; 4-hour Intervention)
- Age 65 years or older at screening.
- No self-reported diagnosis of a serious mental disorder (for example, psychotic disorder or bipolar disorder).
- Sufficient ability to read and understand Spanish to participate in study procedures.
- Adequate cognitive and communication abilities to engage in guided interaction and complete questionnaires.
- Able and willing to provide written informed consent.
- \---
- Arm 1: Healthy Adults
- Current acute medical or psychiatric condition that would compromise safe participation or data validity.
- Moderate or high acute suicide or self-harm risk at screening.
- Significant cognitive, communication, or comprehension impairment that would interfere with participation.
- Explicit refusal to participate.
- \---
- Arm 2: Adults with DSM-5 Diagnosed Mental Disorder in Residential Care
- Current acute psychiatric decompensation requiring crisis-level care.
- Moderate or high acute suicide or self-harm risk at screening or baseline.
- High risk of clinically significant emotional harm from autobiographical life review, defined as treating clinician judgment that narrative or reminiscence work is contraindicated due to one or more of the following:
- Severe clinical destabilization within the past 3 months.
- Trauma-related re-experiencing symptoms.
- Marked dissociative symptoms.
- Inability to provide informed consent, with no legal representative available when required, or lack of participant assent when applicable.
- Significant cognitive, communication, or comprehension impairment without available supports.
- Explicit refusal to participate.
- Imminent discharge or transfer that would prevent completion of the intervention or post-assessment.
- \---
- Arm 3: Healthy Older Adults
- Self-reported diagnosis of a serious mental disorder (for example, psychotic disorder or bipolar disorder).
- Moderate or high acute suicide or self-harm risk at screening.
- Current acute medical or psychiatric condition that would compromise safe participation.
- Significant cognitive, communication, or comprehension impairment that would interfere with participation.
- Explicit refusal to participate.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Barcelona, Spain
- Cerdanyola del Vallès, Barcelona, Spain
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Barcelona, Spain; Cerdanyola del Vallès, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.